Archetype: Service Delivery System. Purpose-built vertical optometry software almost certainly runs the clinical core (imaging, exam records, billing), and the specialty service lines (Ortho-K, IPL series, MiSight) are protocol-driven service delivery. The tell that holds it at Service Delivery System rather than Automation-Ready is the paper intake and absent online scheduling: the vertical software runs the clinic, but the patient-facing operational layer is still manual. Moving toward Automation-Ready Operator once intake and recall are digitized.
Capability Ladder: currently rung 2 → target rung 3 in 12 months.
| Dimension | Score | Note |
|---|---|---|
| Lead speed | 3 | Specialty referrals and reputation soften lead-speed pressure, but no online booking means after-hours and weekend inquiries leak to chains and online retailers. Moderate. |
| Customer communication | 4 | Patients in 2026 expect text-first confirmations, digital intake, and easy specialty follow-up scheduling. Paper forms and phone-only contact lag those expectations, especially for busy parents in myopia management. |
| Cost control | 3 | Vision-plan reimbursement compression is real, but the cash-pay specialty mix (IPL/RF/LLLT, Ortho-K) and designer optical retail give healthier margins than a commodity exam mill. Moderate. |
| Staff efficiency | 4 | Paper re-keying, phone-tag scheduling, and manual recall for multi-visit specialty series consume front-desk hours that a two-doctor practice cannot easily add headcount to absorb. |
| Compliance | 5 | HIPAA/PHI is non-negotiable, paper intake adds physical-record exposure, and pediatric myopia patients add minor-records sensitivity. Highest-pressure dimension. |
| Reporting | 3 | Owners likely can pull production and payer reports from the PM system, but specialty-line ROI (dry-eye device payback, myopia cohort retention) is probably not reported cleanly. Moderate. |
| Digital experience | 4 | Strong clinical brand, but the digital surface (no self-scheduling, paper forms, brochure site) undersells a premium designer-and-specialty practice. High. |
Top pressures: Compliance, Customer communication.
| Use case | Value | Ease | Data | Risk | SaaS dep | Human | Score | Verdict |
|---|---|---|---|---|---|---|---|---|
| Digital patient intake plus paper-form replacement (with PHI controls) | 5 | 4 | 4 | 4 | 3 | Y | 4 | Ship first. Pick a HIPAA-BAA digital intake tool; AI drafts and structures, staff reviews. Replaces the paper-and-re-key loop. |
| Specialty recall plus reactivation campaigns (dry-eye series, annual myopia, lapsed patients) | 5 | 4 | 3 | 4 | 3 | Y | 3.8 | Ship in 30-45 days. AI drafts segment-specific recall copy; staff approves and sends from the PM/EHR. Highest compounding value. |
| Review response plus reputation drafting (Yelp/Google) | 4 | 5 | 4 | 4 | 5 | Y | 4.4 | Quick win. AI drafts on-brand, HIPAA-safe replies (never confirm care details); owner approves. Reinforces the reputation moat. |
| Patient-education drafting for specialty lines (myopia, Ortho-K, dry-eye therapies) | 4 | 5 | 4 | 4 | 5 | Y | 4.4 | Quick win. AI drafts plain-language explainers and pre-visit emails; doctor reviews for clinical accuracy before use. |
| Front-desk phone/FAQ triage assistant (hours, insurance, specialty questions) | 4 | 3 | 3 | 3 | 3 | Y | 3.2 | Phase 2. Useful for call deflection but needs guardrails; never gives clinical advice, routes anything medical to staff. |
Competitive pressure is moderate to high (6/10). The threats are not other independents but national chains and online retailers (LensCrafters, Costco Optical, Warby Parker, online contact sellers) on the commodity exam-and-glasses business, plus a handful of Tri-Valley ODs now marketing the same dry-eye and myopia services. Pleasanton Optometry competes up, not down: device-based dry-eye therapy and myopia management are hard for chains to replicate. Its stack edge is clinical, not operational, and rivals with online booking and digital intake look more modern at the front door even when they are clinically behind.
Two distinct customers: the parent of a myopic 8-to-16-year-old shopping for progression control, and the 40-plus professional with chronic dry eye who wants real treatment, not eye drops. Both expect text confirmations, digital forms, easy multi-visit scheduling, and clear out-of-pocket pricing on uncovered specialty care. The gap: a premium clinical experience funneled through paper forms and phone tag. The parent especially, juggling kids and work, feels the friction first.
Three shifts matter. (1) Myopia management is going mainstream as childhood myopia rates climb; demand for MiSight and Ortho-K is rising (high). (2) Dry-eye device therapy (IPL, RF, LLLT, thermal) is shifting from novelty to expected specialty offering, with cash-pay economics (high). (3) Patient-experience digitization (online scheduling, digital intake, text comms) is now table stakes even in healthcare (high). The practice is ahead on the first two and behind on the third.
Strengths: deep specialty differentiation (full dry-eye device suite plus myopia program) and a 30-year trusted two-doctor brand. Weaknesses: manual paper-based front office, and key-person concentration in the owning couple. Opportunity: convert clinical leadership into an operational recall-and-education engine that compounds patient lifetime value. Threat: chains and online retailers commoditizing the exam-and-eyewear base while a modern-feeling competitor markets the same specialty lines. Porter's: supplier power moderate (device and lens vendors), buyer power moderate (insured patients price-shop eyewear, less so specialty care), rivalry moderate, substitutes real on commodity lines, new-entrant threat low on the specialty side.
Positioning is premium and largely coherent: designer-only optical, full cash-pay dry-eye device menu, and a structured myopia program all signal a high-touch practice, supported by FSA/HSA and CareCredit financing. The misalignment is experiential, not numeric: a premium-priced practice that still hands patients a paper PDF to print at home undercuts the price story. Exact specialty pricing is Unknown, verify; recommend confirming dry-eye package and Ortho-K fee structure before any ROI modeling.
Lead mix is almost certainly referral- and reputation-heavy (word of mouth, existing-patient loyalty, doctor referrals for dry eye), plus organic web and Yelp. The clear leak: no online self-scheduling, so after-hours and weekend intent (when busy parents and professionals actually book) bleeds to whoever answers fastest online. Quick win: add online scheduling and a specialty-specific landing-to-booking path for myopia and dry-eye so marketing spend converts instead of dead-ending at a phone number.
Worst friction is at Booking/Inquiry and First Visit. A patient discovers the practice online, then hits a phone-only contact and a print-at-home paper form, the two least modern moments in an otherwise premium journey. Service Delivery (the clinical exam and specialty treatment) is strong. Follow-up and Retention are under-leveraged: multi-visit dry-eye series and annual myopia recall are exactly where automated, personalized communication would lift both outcomes and revenue.
Rough drag math: if paper intake re-keying, phone-tag scheduling, and manual specialty recall consume even 12 staff hours a week at a loaded $35/hr, that is about 12 x 35 x 52 = $21,840/year of avoidable admin cost, before counting revenue lost to unbooked after-hours demand and lapsed-but-recallable specialty patients. The two gaps that drive it: paper intake and manual recall. Digitizing both is the clearest payback.
High: HIPAA/PHI exposure, amplified by paper intake (physical records to handle, store, and destroy) and pediatric myopia records (minor-record sensitivity). High: clinical-accuracy risk on any patient-facing AI, which must never give clinical advice and must be human-reviewed. High: key-person dependency on the owning couple (capacity and succession). Medium: thin front-office process documentation and an unverified EHR/PM system of record. Any tool added must sign a HIPAA BAA, full stop.
Most realistic expansion is depth before breadth: grow the dry-eye and myopia programs (cohort recall, patient education, referral relationships with local pediatricians and PCPs) rather than open a second location or chase commodity eyewear volume. Prerequisite operational work: digital intake, online scheduling, and a recall engine, the same foundations the AI use cases need. A second location is a 3-to-5-year option only after the front office is systematized and key-person risk is reduced.
Myopia management and device-based dry-eye are a genuine 10x shift in optometry, and Pleasanton Optometry has already crossed the clinical side of that inflection. The trap is treating the operational side as business-as-usual. The one truthful OKR for the next 90 days is specialty-patient retention and recall completion (percent of dry-eye series and annual myopia visits actually rebooked), because that is where the clinical inflection either compounds into a moat or leaks away.
The moat is 30 years of trust plus a device-and-protocol specialty franchise that chains cannot easily copy. The AI that widens it is unglamorous: digital intake, specialty recall, and reputation continuity, all of which improve owner economics by raising patient lifetime value and freeing two scarce doctors. Anything that automates warmth out of a relationship practice weakens the moat and should be declined.
Do not rip out the EHR or the 30-year routines; empower the front desk. The leverage is giving the existing staff an AI assistant that drafts intake summaries, recall messages, and review replies so two people handle a premium specialty caseload without burning out. Refactor the paper-and-phone layer; keep everything clinical that already works.
The surest failure path: a tool that touches PHI without a BAA, or a patient-facing assistant that drifts into clinical advice, triggering a HIPAA or accuracy incident that costs a trust-based practice far more than the efficiency gained. Second-order risk: automating recall so impersonally that loyal patients feel processed. Protect against both first: BAA-gated tools, human review on everything clinical, and on-brand warm copy.
AI Strategy Jumpstart · $5,000 / 4 weeks
Stack score 48 with a strong clinical core but a manual, paper-based front office and no clear operations owner. Four weeks of advisory to stand up digital intake, online scheduling, and a specialty-recall engine, the foundations every later AI move depends on, without over-committing a two-doctor practice.
Your dry-eye and myopia programs are clinically ahead of almost every chain in the Tri-Valley, but new patients still print a paper form and call to book. If we made the front door as modern as the exam room, and turned specialty recall into a measured number, what would that be worth to the practice this year?